$1.66 (6.41%)

Volume: 8.951k

Closed: Dec 02, 2022

Hollow Logo Score: 0.764

Evoke Pharma Stock Forecast

$1.66 (6.41%)

Volume: 8.951k

Closed: Dec 02, 2022

Score Hollow Logo 0.764

Evoke Pharma Stock Statistics NASDAQ:EVOK

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-12-02 - 2022-12-02 HOLD 0
2022-12-01 - 2022-12-02 SELL 6.41
2022-11-30 - 2022-12-01 HOLD 0.652
2022-11-16 - 2022-11-30 SELL -6.35
2022-11-15 - 2022-11-16 HOLD -2.65

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About Evoke Pharma

Evoke Pharma Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine ... EVOK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE